![]() |
|
|
Vol. 290, Issue 3, 1026-1033, September 1999
Faculty of Pharmaceutical Sciences, Chiba University, Chiba, Japan
(T.M., T.Kun., K.K., K.I.); College of Pharmacy, Nihon University,
Funabashi, Japan (T.Kus.); and Department of Physiology and
Pharmacology, State University of New York Health Science Center at
Brooklyn, Brooklyn, New York (K.W.)
The effects of aminoglycoside antibiotics on
N-methyl-D-aspartate (NMDA) receptors were
studied using voltage-clamp recording of recombinant NMDA receptors
expressed in Xenopus oocytes. A number of
aminoglycosides were found to potentiate macroscopic currents at
heteromeric NR1A/NR2B receptors, but not at
NR1A/NR2A, NR1A/NR2C, NR1A/NR2D, or
NR1B/NR2B receptors. The degree of potentiation had a rank
order neomycin B > paromomycin > gentamicin C > geneticin > kanamycin A > streptomycin. Potentiation was
not seen with kasugamycin and spectinomycin. The degree of stimulation
paralleled the number of the amino groups in the aminoglycosides. The
stimulatory effects of aminoglycosides were more pronounced at
subsaturating concentrations of glycine and at acidic pH, similar to
the stimulatory effects of spermine. We measured the effects of
aminoglycosides at mutant NMDA receptors to determine which amino acid
residues in NMDA receptor subunits are involved in stimulation.
Mutations that reduced or abolished spermine stimulation also reduced
stimulation by aminoglycosides. Several aminoglycosides produced a weak
voltage-dependent block of NMDA receptors, but the degree of inhibition
did not appear to correlate with the number of amino groups in the
molecule. The results suggest that aminoglycosides having more than
three amino groups have stimulatory effects that are mediated through the spermine-binding site on NMDA receptors.